Maven Securities’s Terns Pharmaceuticals TERN Stock Holding History

Maven Securities’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-375,000	Closed	-$19.8M	–	452
2026 Q1	$19.8M	Buy	375,000 +345,000	+1,150%	+$14.2M	0.38%	57
2025 Q4	$1.21M	Buy	+30,000	New	+$693K	0.03%	368

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Maven Securities's TERN Position: Q2 2026 in Review

Maven Securities sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 375,000 shares — an estimated $19.8M sold.

Maven Securities first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $19.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Maven Securities reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Maven Securities sold 375,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $19.8M.
Maven Securities first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Maven Securities's Terns Pharmaceuticals position peaked at $19.8M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.